CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
Go back to CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing| (NASDAQ: CDNA) | Delayed: 25.06 +0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.05 | 52 Week High | $6.87 | |||
| Open | $24.70 | 52 Week Low | $3.28 | |||
| Day High | $25.65 | P/E | N/A | |||
| Day Low | $24.50 | EPS | $0.00 | |||
| Volume | 163,637 | |||||

